Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 246 entries
Sorted by: Best Match Show Resources per page
British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction.

BJU international

Biers SM, Harding C, Belal M, Thiruchelvam N, Hamid R, Sahai A, Parkinson R, Barratt R, Ali A, Reid S.
PMID: 33772995
BJU Int. 2021 Mar 26; doi: 10.1111/bju.15402. Epub 2021 Mar 26.

OBJECTIVES: To report the British Association of Urological Surgeon's (BAUS) guidance on the assessment and management of female voiding dysfunction.METHODS: A contemporary literature search was conducted to identify the evidence base. The BAUS Section of Female, Neurological and Urodynamic...

Cite
Biers SM, Harding C, Belal M, et al. British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction. BJU Int. 2021;doi: 10.1111/bju.15402.
Biers, S. M., Harding, C., Belal, M., Thiruchelvam, N., Hamid, R., Sahai, A., Parkinson, R., Barratt, R., Ali, A., Reid, S. (2021). British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction. BJU international, . https://doi.org/10.1111/bju.15402
Biers, Suzanne M, et al. "British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction." BJU international vol. (2021). doi: https://doi.org/10.1111/bju.15402
Biers SM, Harding C, Belal M, Thiruchelvam N, Hamid R, Sahai A, Parkinson R, Barratt R, Ali A, Reid S. British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction. BJU Int. 2021 Mar 26; doi: 10.1111/bju.15402. Epub 2021 Mar 26. PMID: 33772995.
Copy Download .nbib Format: NLM
British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction.

BJU international

Biers SM, Harding C, Belal M, Thiruchelvam N, Hamid R, Sahai A, Parkinson R, Barratt R, Ali A, Reid S.
PMID: 33772995
BJU Int. 2021 Mar 26; doi: 10.1111/bju.15402. Epub 2021 Mar 26.

OBJECTIVES: To report the British Association of Urological Surgeon's (BAUS) guidance on the assessment and management of female voiding dysfunction.METHODS: A contemporary literature search was conducted to identify the evidence base. The BAUS Section of Female, Neurological and Urodynamic...

Cite
Biers SM, Harding C, Belal M, et al. British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction. BJU Int. 2021;doi: 10.1111/bju.15402.
Biers, S. M., Harding, C., Belal, M., Thiruchelvam, N., Hamid, R., Sahai, A., Parkinson, R., Barratt, R., Ali, A., Reid, S. (2021). British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction. BJU international, . https://doi.org/10.1111/bju.15402
Biers, Suzanne M, et al. "British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction." BJU international vol. (2021). doi: https://doi.org/10.1111/bju.15402
Biers SM, Harding C, Belal M, Thiruchelvam N, Hamid R, Sahai A, Parkinson R, Barratt R, Ali A, Reid S. British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction. BJU Int. 2021 Mar 26; doi: 10.1111/bju.15402. Epub 2021 Mar 26. PMID: 33772995.
Copy Download .nbib Format: NLM
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link.

International journal of immunogenetics

Selvaskandan H, Barratt J, Cheung CK.
PMID: 34821031
Int J Immunogenet. 2021 Nov 24; doi: 10.1111/iji.12561. Epub 2021 Nov 24.

IgA nephropathy (IgAN) is the most common pattern of primary glomerular disease reported worldwide. Up to 40% of those with IgAN progress to end-stage kidney disease within 20 years of diagnosis, with no currently available disease-specific treatment. This is...

Cite
Selvaskandan H, Barratt J, Cheung CK. Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link. Int J Immunogenet. 2021;doi: 10.1111/iji.12561.
Selvaskandan, H., Barratt, J., & Cheung, C. K. (2021). Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link. International journal of immunogenetics, . https://doi.org/10.1111/iji.12561
Selvaskandan, Haresh, et al. "Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link." International journal of immunogenetics vol. (2021). doi: https://doi.org/10.1111/iji.12561
Selvaskandan H, Barratt J, Cheung CK. Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link. Int J Immunogenet. 2021 Nov 24; doi: 10.1111/iji.12561. Epub 2021 Nov 24. PMID: 34821031.
Copy Download .nbib Format: NLM
Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients.

Contemporary clinical trials

Diehl TM, Barrett JR, Abbott DE, Cherney Stafford LM, Hanlon BM, Yang Q, Van Doorn R, Weber SM, Voils CI.
PMID: 34954099
Contemp Clin Trials. 2021 Dec 22;113:106658. doi: 10.1016/j.cct.2021.106658. Epub 2021 Dec 22.

BACKGROUND: Hospital readmissions are estimated to cost $17.4 billion per year in the Medicare population alone, with readmission rates as high as 30% for patients undergoing complex abdominal surgery. Improved transitional care and self-monitoring may reduce preventable readmissions for...

Cite
Diehl TM, Barrett JR, Abbott DE, et al. Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients. Contemp Clin Trials. 2021;113:106658doi: 10.1016/j.cct.2021.106658.
Diehl, T. M., Barrett, J. R., Abbott, D. E., Cherney Stafford, L. M., Hanlon, B. M., Yang, Q., Van Doorn, R., Weber, S. M., & Voils, C. I. (2021). Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients. Contemporary clinical trials, 113106658. https://doi.org/10.1016/j.cct.2021.106658
Diehl, Thomas M, et al. "Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients." Contemporary clinical trials vol. 113 (2021): 106658. doi: https://doi.org/10.1016/j.cct.2021.106658
Diehl TM, Barrett JR, Abbott DE, Cherney Stafford LM, Hanlon BM, Yang Q, Van Doorn R, Weber SM, Voils CI. Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients. Contemp Clin Trials. 2021 Dec 22;113:106658. doi: 10.1016/j.cct.2021.106658. Epub 2021 Dec 22. PMID: 34954099.
Copy Download .nbib Format: NLM
Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients.

Contemporary clinical trials

Diehl TM, Barrett JR, Abbott DE, Cherney Stafford LM, Hanlon BM, Yang Q, Van Doorn R, Weber SM, Voils CI.
PMID: 34954099
Contemp Clin Trials. 2021 Dec 22;113:106658. doi: 10.1016/j.cct.2021.106658. Epub 2021 Dec 22.

BACKGROUND: Hospital readmissions are estimated to cost $17.4 billion per year in the Medicare population alone, with readmission rates as high as 30% for patients undergoing complex abdominal surgery. Improved transitional care and self-monitoring may reduce preventable readmissions for...

Cite
Diehl TM, Barrett JR, Abbott DE, et al. Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients. Contemp Clin Trials. 2021;113:106658doi: 10.1016/j.cct.2021.106658.
Diehl, T. M., Barrett, J. R., Abbott, D. E., Cherney Stafford, L. M., Hanlon, B. M., Yang, Q., Van Doorn, R., Weber, S. M., & Voils, C. I. (2021). Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients. Contemporary clinical trials, 113106658. https://doi.org/10.1016/j.cct.2021.106658
Diehl, Thomas M, et al. "Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients." Contemporary clinical trials vol. 113 (2021): 106658. doi: https://doi.org/10.1016/j.cct.2021.106658
Diehl TM, Barrett JR, Abbott DE, Cherney Stafford LM, Hanlon BM, Yang Q, Van Doorn R, Weber SM, Voils CI. Protocol for the MobiMD trial: A randomized controlled trial to evaluate the effect of a self-monitoring mobile app on hospital readmissions for complex surgical patients. Contemp Clin Trials. 2021 Dec 22;113:106658. doi: 10.1016/j.cct.2021.106658. Epub 2021 Dec 22. PMID: 34954099.
Copy Download .nbib Format: NLM
IgA nephropathy: a perspective for 2021.

Seminars in immunopathology

Floege J, Barratt J.
PMID: 34705062
Semin Immunopathol. 2021 Oct;43(5):625-626. doi: 10.1007/s00281-021-00890-9.

No abstract available.

Cite
Floege J, Barratt J. IgA nephropathy: a perspective for 2021. Semin Immunopathol. 2021;43(5):625-626doi: 10.1007/s00281-021-00890-9.
Floege, J., & Barratt, J. (2021). IgA nephropathy: a perspective for 2021. Seminars in immunopathology, 43(5), 625-626. https://doi.org/10.1007/s00281-021-00890-9
Floege, Jürgen, and Barratt, Jonathan. "IgA nephropathy: a perspective for 2021." Seminars in immunopathology vol. 43,5 (2021): 625-626. doi: https://doi.org/10.1007/s00281-021-00890-9
Floege J, Barratt J. IgA nephropathy: a perspective for 2021. Semin Immunopathol. 2021 Oct;43(5):625-626. doi: 10.1007/s00281-021-00890-9. PMID: 34705062; PMCID: PMC8551095.
Copy Download .nbib Format: NLM
Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination.

Journal of neuropathology and experimental neurology

Prineas JW, Parratt JDE.
PMID: 34553215
J Neuropathol Exp Neurol. 2021 Oct 26;80(10):975-996. doi: 10.1093/jnen/nlab083.

This study examined the roles of microglia and monocytes in myelin destruction in patients with early multiple sclerosis (MS). Twenty-two cases were studied; the clinical duration was

Cite
Prineas JW, Parratt JDE. Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination. J Neuropathol Exp Neurol. 2021;80(10):975-996doi: 10.1093/jnen/nlab083.
Prineas, J. W., & Parratt, J. D. E. (2021). Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination. Journal of neuropathology and experimental neurology, 80(10), 975-996. https://doi.org/10.1093/jnen/nlab083
Prineas, John W, and Parratt, John D E. "Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination." Journal of neuropathology and experimental neurology vol. 80,10 (2021): 975-996. doi: https://doi.org/10.1093/jnen/nlab083
Prineas JW, Parratt JDE. Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination. J Neuropathol Exp Neurol. 2021 Oct 26;80(10):975-996. doi: 10.1093/jnen/nlab083. PMID: 34553215; PMCID: PMC8557350.
Copy Download .nbib Format: NLM
The aryl hydrocarbon receptor as a model PAS sensor.

Toxicology reports

Vazquez-Rivera E, Rojas B, Parrott JC, Shen AL, Xing Y, Carney PR, Bradfield CA.
PMID: 34950569
Toxicol Rep. 2021 Nov 26;9:1-11. doi: 10.1016/j.toxrep.2021.11.017. eCollection 2022.

Proteins containing PER-ARNT-SIM (PAS) domains are commonly associated with environmental adaptation in a variety of organisms. The PAS domain is found in proteins throughout Archaea, Bacteria, and Eukarya and often binds small-molecules, supports protein-protein interactions, and transduces input signals...

Cite
Vazquez-Rivera E, Rojas B, Parrott JC, et al. The aryl hydrocarbon receptor as a model PAS sensor. Toxicol Rep. 2021;9:1-11doi: 10.1016/j.toxrep.2021.11.017.
Vazquez-Rivera, E., Rojas, B., Parrott, J. C., Shen, A. L., Xing, Y., Carney, P. R., & Bradfield, C. A. (2022). The aryl hydrocarbon receptor as a model PAS sensor. Toxicology reports, 91-11. https://doi.org/10.1016/j.toxrep.2021.11.017
Vazquez-Rivera, Emmanuel, et al. "The aryl hydrocarbon receptor as a model PAS sensor." Toxicology reports vol. 9 (2022): 1-11. doi: https://doi.org/10.1016/j.toxrep.2021.11.017
Vazquez-Rivera E, Rojas B, Parrott JC, Shen AL, Xing Y, Carney PR, Bradfield CA. The aryl hydrocarbon receptor as a model PAS sensor. Toxicol Rep. 2021 Nov 26;9:1-11. doi: 10.1016/j.toxrep.2021.11.017. eCollection 2022. PMID: 34950569; PMCID: PMC8671103.
Copy Download .nbib Format: NLM
Acute Hemichorea-Hemiballismus Following COVID-19 (AZD1222) Vaccination.

Movement disorders : official journal of the Movement Disorder Society

Matar E, Manser D, Spies JM, Worthington JM, Parratt KL.
PMID: 34581453
Mov Disord. 2021 Dec;36(12):2714-2715. doi: 10.1002/mds.28796. Epub 2021 Sep 28.

No abstract available.

Cite
Matar E, Manser D, Spies JM, et al. Acute Hemichorea-Hemiballismus Following COVID-19 (AZD1222) Vaccination. Mov Disord. 2021;36(12):2714-2715doi: 10.1002/mds.28796.
Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea-Hemiballismus Following COVID-19 (AZD1222) Vaccination. Movement disorders : official journal of the Movement Disorder Society, 36(12), 2714-2715. https://doi.org/10.1002/mds.28796
Matar, Elie, et al. "Acute Hemichorea-Hemiballismus Following COVID-19 (AZD1222) Vaccination." Movement disorders : official journal of the Movement Disorder Society vol. 36,12 (2021): 2714-2715. doi: https://doi.org/10.1002/mds.28796
Matar E, Manser D, Spies JM, Worthington JM, Parratt KL. Acute Hemichorea-Hemiballismus Following COVID-19 (AZD1222) Vaccination. Mov Disord. 2021 Dec;36(12):2714-2715. doi: 10.1002/mds.28796. Epub 2021 Sep 28. PMID: 34581453; PMCID: PMC8661968.
Copy Download .nbib Format: NLM
Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020.

The Journal of infectious diseases

Barratt J, Ahart L, Rice M, Houghton K, Richins T, Cama V, Arrowood M, Qvarnstrom Y, Straily A.
PMID: 34606577
J Infect Dis. 2021 Oct 04; doi: 10.1093/infdis/jiab495. Epub 2021 Oct 04.

Cyclosporiasis is a diarrheal illness caused by the food-borne parasite Cyclospora cayetanensis. Annually reported cases have been increasing in the United States prompting development of genotyping tools to aid cluster detection. A recently developed Cyclospora genotyping system based on...

Cite
Barratt J, Ahart L, Rice M, et al. Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020. J Infect Dis. 2021;doi: 10.1093/infdis/jiab495.
Barratt, J., Ahart, L., Rice, M., Houghton, K., Richins, T., Cama, V., Arrowood, M., Qvarnstrom, Y., & Straily, A. (2021). Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiab495
Barratt, Joel, et al. "Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020." The Journal of infectious diseases vol. (2021). doi: https://doi.org/10.1093/infdis/jiab495
Barratt J, Ahart L, Rice M, Houghton K, Richins T, Cama V, Arrowood M, Qvarnstrom Y, Straily A. Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020. J Infect Dis. 2021 Oct 04; doi: 10.1093/infdis/jiab495. Epub 2021 Oct 04. PMID: 34606577.
Copy Download .nbib Format: NLM
Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review.

European urology

Barratt R, Chan G, La Rocca R, Dimitropoulos K, Martins FE, Campos-Juanatey F, Greenwell TJ, Waterloos M, Riechardt S, Osman NI, Yuan Y, Esperto F, Ploumidis A, Lumen N.
PMID: 33875306
Eur Urol. 2021 Jul;80(1):57-68. doi: 10.1016/j.eururo.2021.03.026. Epub 2021 Apr 17.

CONTEXT: Four techniques for graft placement in one-stage bulbar urethroplasty have been reported: dorsal onlay (DO), ventral onlay (VO), dorsolateral onlay (DLO), and dorsal inlay (DI). There is currently no systematic review in the literature comparing these techniques.OBJECTIVE: To...

Cite
Barratt R, Chan G, La Rocca R, et al. Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review. Eur Urol. 2021;80(1):57-68doi: 10.1016/j.eururo.2021.03.026.
Barratt, R., Chan, G., La Rocca, R., Dimitropoulos, K., Martins, F. E., Campos-Juanatey, F., Greenwell, T. J., Waterloos, M., Riechardt, S., Osman, N. I., Yuan, Y., Esperto, F., Ploumidis, A., Lumen, N. (2021). Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review. European urology, 80(1), 57-68. https://doi.org/10.1016/j.eururo.2021.03.026
Barratt, Rachel, et al. "Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review." European urology vol. 80,1 (2021): 57-68. doi: https://doi.org/10.1016/j.eururo.2021.03.026
Barratt R, Chan G, La Rocca R, Dimitropoulos K, Martins FE, Campos-Juanatey F, Greenwell TJ, Waterloos M, Riechardt S, Osman NI, Yuan Y, Esperto F, Ploumidis A, Lumen N. Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review. Eur Urol. 2021 Jul;80(1):57-68. doi: 10.1016/j.eururo.2021.03.026. Epub 2021 Apr 17. PMID: 33875306.
Copy Download .nbib Format: NLM
A challenging outbreak of New Delhi metallo-β-lactamase-5 producing Klebsiella pneumoniae in a New Zealand Tertiary Hospital: A case report.

Infection, disease & health

Barratt R, Brown L, O'Callaghan M.
PMID: 31862090
Infect Dis Health. 2017 Sep;22(3):144-149. doi: 10.1016/j.idh.2017.05.001. Epub 2017 May 17.

No abstract available.

Cite
Barratt R, Brown L, O'Callaghan M. A challenging outbreak of New Delhi metallo-β-lactamase-5 producing Klebsiella pneumoniae in a New Zealand Tertiary Hospital: A case report. Infect Dis Health. 2017;22(3):144-149doi: 10.1016/j.idh.2017.05.001.
Barratt, R., Brown, L., & O'Callaghan, M. (2017). A challenging outbreak of New Delhi metallo-β-lactamase-5 producing Klebsiella pneumoniae in a New Zealand Tertiary Hospital: A case report. Infection, disease & health, 22(3), 144-149. https://doi.org/10.1016/j.idh.2017.05.001
Barratt, Ruth, et al. "A challenging outbreak of New Delhi metallo-β-lactamase-5 producing Klebsiella pneumoniae in a New Zealand Tertiary Hospital: A case report." Infection, disease & health vol. 22,3 (2017): 144-149. doi: https://doi.org/10.1016/j.idh.2017.05.001
Barratt R, Brown L, O'Callaghan M. A challenging outbreak of New Delhi metallo-β-lactamase-5 producing Klebsiella pneumoniae in a New Zealand Tertiary Hospital: A case report. Infect Dis Health. 2017 Sep;22(3):144-149. doi: 10.1016/j.idh.2017.05.001. Epub 2017 May 17. PMID: 31862090.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 246 entries